treatment for small intestinal bacterial overgrowth

#TREATMENT FOR SMALL INTESTINAL BACTERIAL OVERGROWTH SOFTWARE#

Different individuals may respond to medication in different ways. Our phase IV clinical studies alone cannot establish cause-effect relationship. WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.ĭISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider.

#TREATMENT FOR SMALL INTESTINAL BACTERIAL OVERGROWTH SOFTWARE#

Our analysis results are available to researchers, health care professionals, patients ( testimonials), and software developers ( open API). Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. We study millions of patients and 5,000 more each day. Probiotics have been explored in several trials to prevent and treat SIBO, and this is the first systematic review and meta-analysis to investigate their efficacy.With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. However, this treatment strategy is not without its problems. SIBO is typically treated with antibiotic drugs. A condition called small intestinal bacterial overgrowth (SIBO) is characterized by excess bacteria in the small intestine, which can damage the lining and cause symptoms similar to irritable bowel syndrome (IBS). The study under review is the first meta-analysis to pool the results of several trials exploring the use of probiotics to prevent or treat SIBO. Probiotics have been explored in several trials as an alternative to antibiotics to prevent SIBO occurrence and to treat SIBO. In addition, antibiotics may not always work for everyone. Unfortunately, these drugs may not be ideal for longterm use because of the possibility of producing antibiotic resistant bacteria or disrupting the microbiome in the gastrointestinal tract. Treatments typically involve the use of antibiotic drugs to reduce bacterial counts. Researchers believe that the factors that may lead to SIBO include gastrointestinal infections, disrupted motility of the small intestine, or low production of stomach acid.

However, this is somewhat invasive, so it’s not used as often. The gold standard for diagnosis is to take a sample from the small intestine and measure the concentration of bacteria in that sample. One commonly used method is to administer certain carbohydrates to a patient and measure hydrogen breath levels over a period of time, a process depicted in Figure 1. īut unlike IBS, SIBO can be diagnosed using biomarkers. Many of the symptoms of SIBO, such as nausea, abdominal pain, and altered bowel habits, are similar to irritable bowel syndrome (IBS), and some people with IBS may be likely to have SIBO.

The excess bacteria seem to decrease the amount of nutrients absorbed from food, damage the lining of the small intestine, and produce toxins that can pass into the blood. What happens when bacteria proliferate in regions they’re not supposed to be in? In a disorder known as “small intestinal bacterial overgrowth” (SIBO), the small intestines of affected individuals have higher concentrations of bacteria, relative to people without the disorder. This is useful because these microbes break down indigestible fibers, produce shortchain fatty acids that fuel the cells of the colon, and train immune system cells. The large intestine, on the other hand, can contain up to 10 trillion microbes per gram of intestinal content. Also, a lot of bacteria in the small intestine would lead to competition for the nutrients that are absorbed. This makes sense since the small intestine, filled with bile and enzymes, is pretty inhospitable. So, we are literally surrounded and colonized by microorganisms, yet they prefer to live in some places more than others.įor example, the stomach and the upper regions of the small intestine contain less than 10,000 microorganisms/mL of intestinal secretions. In one hour, a person’s mere presence in a room can increase the bacterial count in the air by 37 million.

Treatment for small intestinal bacterial overgrowth